A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells.
Harris KE, Lorentsen KJ, Malik-Chaudhry HK, Loughlin K, Basappa HM, Hartstein S, Ahmil G, Allen NS, Avanzino BC, Balasubramani A, Boudreau AA, Chang K, Cuturi MC, Davison LM, Ho DM, Iyer S, Rangaswamy US, Sankaran P, Schellenberger U, Buelow R, Trinklein ND.
Harris KE, et al. Among authors: allen ns.
Sci Rep. 2021 May 19;11(1):10592. doi: 10.1038/s41598-021-90096-8.
Sci Rep. 2021.
PMID: 34011961
Free PMC article.